Perception of the Family Burden of Chronic Migraine: Results of the CaMEO (Chronic Migraine Epidemiology & Outcomes) Study (P5.039)

Abstract

OBJECTIVE: The Family Burden Module (FBM) from the CaMEO Study evaluated the extent, nature, and perception of the burden of migraines on probands and their families. BACKGROUND: Chronic migraine (CM) is associated with significant disability and burden; however, the effect on family life, activities, and relationships is not well established. DESIGN/METHODS: Participants were recruited in a series of web-based surveys over 1 year to characterize migraine. The panel surveyed was sociodemographically representative of the US. The FBM-Proband survey assessed 15 domains (134 items), including missed activities with family, partner, and children, and perceived relationship impact. Data from respondents meeting modified CM criteria (International Classification of Headache Disorders, 3rd edition, beta [ICHD-3b] migraine diagnosis + 蠅15 headache days/month for past 3 months; ICHD-3b criterion C not assessed) were included in the current analysis. RESULTS: 11,518 respondents had valid data from the FBM; 994 (8.6[percnt]) probands were classified with CM. Probands reported reduced participation in family activities (6.9 days), reduced enjoyment of quality time with partners (6.6 days), and cancelled plans (4.3 days) within the preceding month. Over the previous year, 20[percnt] reported cancelling a family vacation and 53.6[percnt] reported reduced enjoyment during vacations. Reduced enjoyment at important family events was reported for 9.4 weeks within the previous year. Most probands reported that their headaches made them easily annoyed with their partner (70.2[percnt]) and children (60.6[percnt]) and that their headaches made their partner’s (64.1[percnt]) and children’s (56.5[percnt]) lives more difficult. They believed that they would be better partners (72.5[percnt]) and parents (59.1[percnt]) without headaches. CONCLUSIONS: CM adversely affects family activities and relationships. These findings suggest CM places a significant burden on both probands and their family members. Study Supported by: Allergan, Inc.

Disclosure: Dr. Buse has received personal compensation for activities with Allergan and American Headache Society. Dr. Buse's employer has received research support from Allergan, Zogenix, Novartis, National Headache Founation, and Vedanta Research. Dr. Dodick has received personal compensation for activities with Allergan, Amgen, Arteaus, Alder, Merck, ENeura, NuPathe, Colucid, Eli Lilly & Company, Autonomic Technologies, Supernus, Zogenix, Tonix, Labrys, Alcobra, Intramed, Haymarket Medical Educati Dr. Manack has received personal compensation for activities with Allergan, Inc. as an employee.